Mutations

MAPT R5L

Overview

Pathogenicity: Frontotemporal Dementia : Not Pathogenic, Other Tauopathy : Pathogenic
Clinical Phenotype: Progressive Supranuclear Palsy
Genomic Mutation Name (MET1): g.75756G>T
Genomic Mutation Name (NT1): g.72930G>T
dbSNP ID: rs63750959
Coding/Non-Coding: Coding
Genomic Region: Exon 1
Mutation Type: Point, Missense
Codon Change: CGC to CTC

Findings

This mutation was identified in a screen of MAPT in people with progressive supranuclear palsy. The R5L mutation was identified in one out of 96 PSP patients and in none of the 96 controls. The presenting clinical features of the patient included falls, dysarthria (difficulty pronouncing words), and micrographia (abnormally small, cramped handwriting), with onset at age 62 (Poorkaj et al., 2002).

Biological Effect

This missense mutation alters the ability of the tau protein to promote microtubule assembly. It does not appear to affect the ratio of tau isoforms synthesized (Poorkaj et al., 2002).

Neuropathology

Aggregated insoluble tau in subcortical regions was predominantly 4-repeat (4R) tau with 0 or 1 amino terminal inserts (i.e. 0N4R or 1N4R). Insoluble tau in cortical regions also contained 1N3R tau (Poorkaj et al., 2002).

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

No Available Comments

References

Paper Citations

  1. . An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Ann Neurol. 2002 Oct;52(4):511-6. PubMed.

Further Reading

Learn More

Alzheimer Disease & Frontotemporal Dementia Mutation Database

Primary Papers

  1. . An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Ann Neurol. 2002 Oct;52(4):511-6. PubMed.

Other mutations at this position

View Table